Medical Xpress - Cardiology

DECEMBER 13, 2023

Published results of a large, national heart attack study show that patients with a life-threatening complication known as cardiogenic shock survived at a significantly higher rate when treated with a protocol developed by cardiologists at Henry Ford Health, in collaboration with 80 hospitals nationwide.

Cardiogenic Shock 94

Cardiogenic Shock Heart attacks Heart Attack Hospital 94

CardiacWire

SEPTEMBER 25, 2024

Windtree Therapeutics’ istaroxime appears to have scored in its latest Phase 2b trial , showing that the steroidal drug significantly improves systolic blood pressure in cardiogenic shock patients. That could be a big deal in the cardiogenic shock space, which many believe is still in need of more effective treatments.

Cardiogenic Shock 59

Cardiogenic Shock Blood Pressure Heart Failure Cardiac Function 59

American College of Cardiology

FEBRUARY 1, 2024

What are the characteristics and outcomes of cardiogenic shock (CS) in children hospitalized for acute decompensated heart failure (ADHF)?

Cardiogenic Shock 66

Cardiogenic Shock Outcomes Heart Failure Hospital 66

Circulation

FEBRUARY 26, 2024

Cardiogenic shock continues to portend poor outcomes, conferring short-term mortality rates of 30% to 50% despite recent scientific advances. Age is a nonmodifiable risk factor for mortality in patients with cardiogenic shock and is often considered in the decision-making process for eligibility for various therapies.

Cardiogenic Shock 74

Cardiogenic Shock Best Practices Heart Transplant Transplant 74

Circulation

JANUARY 20, 2025

Advances in critical care therapies for patients with cardiogenic shock (CS), including temporary mechanical circulatory support and multidisciplinary shock teams, have led to improved survival to hospital discharge, ranging from 60% to 70%. Circulation, Volume 151, Issue 3 , Page 257-271, January 21, 2025.

Cardiogenic Shock 58

Cardiogenic Shock Quality of Life Critical Care Hospital 58

The New England Journal of Medicine

MARCH 13, 2024

A 55-year-old man had an out-of-hospital cardiac arrest. An evaluation showed 2-mm ST-segment elevations in the inferior leads on electrocardiography, cardiogenic shock, and a new systolic murmur. A diagnosis was made.

Cardiogenic Shock 67

Cardiogenic Shock Cardiac Arrest Hospital 67

Dr. Smith's ECG Blog

MAY 26, 2023

A 20-something presented after a huge verapamil overdose in cardiogenic shock. Today's patient is a young male who presented in cardiogenic shock following a massive verapamil overdose. He had been seen at an outside institution and been given 6 g calcium gluconate, KCl, and a norepinephrine drip. The initial K was 3.0

Cardiogenic Shock 98

Cardiogenic Shock Arrhythmia Blog Education 98

CardiacWire

FEBRUARY 7, 2025

The “weekend effect” is a well-documented phenomenon in hospital care, often linked to reduced staffing levels, leading to potential delays in diagnosis and intervention. Beyond in-hospital mortality, weekend patients faced a 3.27x higher risk of death following the procedures.

TAVR 59

TAVR Cardiogenic Shock Hospital Cardiac Arrest 59

European Journal of Heart Failure

JANUARY 17, 2025

Predictors of weaning failure from veno-arterial extracorporeal membrane oxygenation (VA-ECMO) in patients with cardiogenic shock. Of the successfully weaned patients, 150 (36.6%) died before hospital discharge. RRT, renal replacement therapy. interquartile range 4.112.7] patients died on or within 48h after VA-ECMO support).

Cardiogenic Shock 66

Cardiogenic Shock Cardiac Arrest Myocardial Infarction Hospital 66

The American Journal of Cardiology

JANUARY 25, 2025

Publication date: Available online 24 January 2025 Source: The American Journal of Cardiology Author(s): Eric J. Hall, Colby R. Ayers, Nicholas S. Hendren, Christopher Clark, Amit Saha, Hadi Beaini, Isabella L. Alexander, Evan P. Gee, Ian R. McConnell, Emily S. Samson, Roslyn J. Saplicki, Christopher S. Grubb, Grant Tucker, Justin L.

Cardiogenic Shock 40

Cardiogenic Shock Hospital Outcomes 40

Becker's Hospital Review - Cardiology

DECEMBER 4, 2024

Baylor Scott & White The Heart Hospital-Plano in Texas cut times of cardiogenic shock diagnosis in half after implementing a quality improvement project that included nurse education and an electronic shock team alert, according to a study published Dec. 1 in Critical Care Nurse.

Cardiogenic Shock 52

Cardiogenic Shock Nursing Education Critical Care 52

HCPLive

JANUARY 14, 2025

AHN's specialized Shock Team at Allegheny General Hospital works to fight against cardiogenic shock.

Cardiogenic Shock 52

Cardiogenic Shock Hospital 52

Journal of the American Heart Association

JANUARY 19, 2024

BackgroundVenoarterial extracorporeal membrane oxygenation (VA‐ECMO) is increasingly used for patients with cardiogenic shock. In‐hospital mortality was higher with ECMO with Impella (54.8%) compared with ECMO only (50.4%) and ECMO with IABP (48.4%). P=0.002), higher in‐hospital mortality (aOR, 1.32;P=0.001),

Cardiogenic Shock 65

Cardiogenic Shock Aortic Hospital Outcomes 65

DAIC

DECEMBER 18, 2024

with SmartAssist and Impella CP with SmartAssist heart pumps, granting premarket approval (PMA) for use in specific pediatric patients with symptomatic acute decompensated heart failure (ADHF) and cardiogenic shock. and Impella CP, both left-sided heart pumps, for pediatric patients with symptomatic ADHF and cardiogenic shock.

Pediatrics 52

Pediatrics Cardiogenic Shock Heart Failure Quality of Life 52

Journal of the American Heart Association

FEBRUARY 16, 2024

BackgroundClinical outcome of ischemic cardiogenic shock (CS) requiring extracorporeal membrane oxygenation is highly variable, necessitating appropriate assessment of prognosis. Fifteen parameters were selected to assess in‐hospital mortality. RegistrationURL:[link] Unique identifier: NCT02985008.

Cardiogenic Shock 45

Cardiogenic Shock Hospital Myocardial Infarction Kidney Disease 45

The New England Journal of Medicine

APRIL 6, 2024

Acute myocardial infarction–related cardiogenic shock (AMI-CS) is characterized by systemic hypoperfusion due to cardiomyocyte necrosis and ventricular dysfunction.1 2 Prompt reperfusion.

Cardiogenic Shock 40

Cardiogenic Shock Myocardial Infarction Hospital 40

Medical Xpress - Cardiology

MAY 2, 2024

A nationwide observational analysis of patients with aortic stenosis (AS) and cardiogenic shock (CS) who underwent transcatheter aortic valve replacement (TAVR) or surgical aortic valve replacement (SAVR) determined that patients who underwent TAVR had lower in-hospital complications and resource utilization compared with SAVR.

Cardiogenic Shock 40

Cardiogenic Shock TAVR Stenosis Aortic valve 40

Medical Xpress - Cardiology

DECEMBER 2, 2024

A cardiovascular specialty hospital in north Texas decreased time to diagnosis for patients with cardiogenic shock by more than half, according to a study published in Critical Care Nurse.

Cardiogenic Shock 40

Cardiogenic Shock Critical Care Nursing Hospital 40

JAMA Cardiology

OCTOBER 26, 2024

In a seminal case series published in 1967, Killip and Kimball reported 81% in-hospital mortality for patients presenting with acute myocardial infarction complicated by cardiogenic shock (AMI-CS).

Cardiogenic Shock 40

Cardiogenic Shock Myocardial Infarction Heart Failure Hospital 40

Journal of the American Heart Association

NOVEMBER 28, 2023

BackgroundAcute myocardial infarction complicated by cardiogenic shock (AMI‐CS) is associated with significant morbidity and mortality. The primary end point was in‐hospital mortality. Survival rates to hospital discharge were high. A total of 406 patients were enrolled at 80 sites between 2016 and 2020.

Cardiogenic Shock 40

Cardiogenic Shock Myocardial Infarction Blood Pressure Cardiac Arrest 40

Frontiers in Cardiovascular Medicine

FEBRUARY 24, 2025

Despite initiating thrombolysis for cerebral infarction and supportive treatments for heart failure, including VA-ECMO, the patient's condition continued to decline, evidenced by cardiogenic shock, heart failure, and progressive neurological deficits including coma and dilated non-reactive pupils.

Atrial Fibrillation 52

Atrial Fibrillation Ablation Cardiogenic Shock Myocardial Infarction 52

European Journal of Heart Failure

FEBRUARY 5, 2025

Aims Among patients with cardiogenic shock, immediate initiation of extracorporeal membrane oxygenation (ECMO) did not demonstrate any benefit at 30days. The present study evaluated 1-year clinical outcomes of the Extracorporeal Membrane Oxygenation in the therapy of Cardiogenic Shock (ECMO-CS) trial.

Cardiogenic Shock 40

Cardiogenic Shock ICU Outcomes Cardiac Arrest 40

Frontiers in Cardiovascular Medicine

DECEMBER 11, 2024

BackgroundPercutaneous extracorporeal membrane oxygenation (ECMO) is administered to pediatric patients with cardiogenic shock or cardiac arrest. The traditional method uses focal echocardiography to complete the left ventricular measurement.

Pediatrics 52

Pediatrics Cardiogenic Shock Cardiac Arrest Echocardiogram 52

Dr. Smith's ECG Blog

FEBRUARY 16, 2020

A previously healthy 53 yo woman was transferred to a receiving hospital in cardiogenic shock. Referring to Figure-1 — this 53-year old woman who presented in extremis with cardiogenic shock and an initial pH = 6.9, This was sent by a reader. and K was normal. Here was the ECG: There is sinus tachycardia.

Cardiogenic Shock 52

Cardiogenic Shock STEMI Pericarditis Blog 52

European Journal of Heart Failure

DECEMBER 13, 2023

Impella and venoarterial extracorporeal membrane oxygenation (VA-ECMO) in patients with acute myocardial infarction-related cardiogenic shock (AMICS). Impella patients were older (34% vs. 13% >75 years, p  < 0.001) and less frequently presented after an out-of-hospital cardiac arrest (18% vs. 40%, p  < 0.001).

Cardiogenic Shock 40

Cardiogenic Shock Myocardial Infarction Cardiac Arrest Hospital 40

Circulation: Cardiovascular Interventions

JANUARY 31, 2024

BACKGROUND:In patients with ST-segment–elevation myocardial infarction complicated by cardiogenic shock, primary percutaneous coronary intervention (pPCI) is the preferred revascularization option. pharmacoinvasive and 46.2% pharmacoinvasive and 46.2% The incidence of the primary safety outcome was 10.1% 1.09];P=0.08).CONCLUSIONS:In

Cardiogenic Shock 40

Cardiogenic Shock Myocardial Infarction Cardiac Arrest Cardiovascular Interventions 40

Dr. Smith's ECG Blog

OCTOBER 20, 2024

Figure B At this point, with the ECG changing from diffuse ST depression to widespread ST elevation and the patient presenting in cardiogenic shock, left main coronary artery (LMCA) occlusion is the likely diagnosis. He was later transferred back to his local hospital neurologically intact and without serious sequela.

Cardiogenic Shock 128

Cardiogenic Shock Ischemia Chest Pain Cardiac Arrest 128

Journal of the American Heart Association

JANUARY 19, 2024

BackgroundVenoarterial extracorporeal membrane oxygenation (ECMO) provides full hemodynamic support for patients with cardiogenic shock, but optimal timing of ECMO initiation remains uncertain. Multivariable logistic regression evaluated the association between time from admission to ECMO initiation and in‐hospital death.

Cardiogenic Shock 40

Cardiogenic Shock Outcomes Cardiac Arrest Hospital 40

Journal of the American Heart Association

FEBRUARY 23, 2024

BackgroundThe effects of pharmacological therapy on cardiogenic shock (CS) survivors have not been extensively studied. Of 772 patients, 535 patients were enrolled in the present analysis following the exclusion of 217 in‐hospital deaths and 20 patients with missing medical records.

Cardiogenic Shock 40

Cardiogenic Shock Heart Failure Pharmacology Hospital 40

European Journal of Heart Failure

DECEMBER 11, 2024

Abstract Worldwide, valvular heart disease (VHD) is a common cause of hospitalization for acute heart failure. In acute heart failure caused by VHD, symptoms result from rapid haemodynamic changes and subsequent decline in cardiac function, and if left untreated, leads to acute decompensation and cardiogenic shock.

Cardiogenic Shock 68

Cardiogenic Shock Heart Disease Heart Failure Bicuspid/Mitral 68

Journal of the American Heart Association

DECEMBER 1, 2023

After adjusting for the confounders, the risk difference in the fourth quarter of 2021 relative to the first quarter of 2019 for in‐hospital mortality was not significant (adjusted odds ratio, 0.84 [95% CI, 0.69–1.01]).ConclusionsOur Journal of the American Heart Association, Volume 12, Issue 23 , December 5, 2023.

Cardiogenic Shock 40

Cardiogenic Shock Outcomes Aortic Hospital 40

Dr. Smith's ECG Blog

MAY 3, 2024

In fact, most do not make it to the hospital alive, which explains why only a tiny percent of OMI are due to full LM occlusion. Some patients have baseline RBBB with LAFB, but in patients with likely ACS, these are associated with severe infarction with cardiac arrest, cardiogenic shock or impending shock.

Cardiogenic Shock 127

Cardiogenic Shock Cardiac Arrest Hospital Ischemia 127

The American Journal of Cardiology

APRIL 6, 2024

Publication date: Available online 5 April 2024 Source: The American Journal of Cardiology Author(s): Amit Saha, Shuang Li, James A. de Lemos, Ambarish Pandey, Deepak L. Bhatt, Gregg C. Fonarow, Brahmajee K. Nallamothu, Tracy Y.MHS WangMSc, Ann Marie Navar, Eric Peterson, Roland A. Matsouaka, Anthony A. Bavry, Sandeep R. Das, Justin L.

Cardiogenic Shock 40

Cardiogenic Shock Myocardial Infarction Hospital 40

European Journal of Heart Failure

DECEMBER 12, 2023

Abstract Objectives This study aimed to assess the impact of anemia and iron deficiency (ID) on clinical outcome in patients with cardiogenic shock (CS) complicating acute myocardial infarction (AMI). ID has no relevant impact on clinical outcome in patients with CS.

Cardiogenic Shock 40

Cardiogenic Shock Myocardial Infarction Outcomes Catheterization Laboratory 40

Frontiers in Cardiovascular Medicine

JULY 21, 2024

After a prolonged in-hospital stay, the patient was discharged in stable condition.

Embolism 59

Embolism Cardiogenic Shock Pulmonary Cardiac Arrest 59

DAIC

JULY 29, 2024

FDA for two clinical indications: high-risk percutaneous coronary intervention (HR-PCI) and cardiogenic shock (CS). The results were presented at the 2023 Transcatheter Cardiovascular Therapeutics (TCT) conference in San Francisco by Dr. Perwaiz Meraj of North Shore University Hospital. Magenta completed a U.S.

Cardiogenic Shock 105

Cardiogenic Shock Blood Pressure Technology Aortic valve 105

Dr. Smith's ECG Blog

SEPTEMBER 5, 2024

She presented to an outside hospital after several days of malaise and feeling unwell. The VSR is what is causing the cardiogenic shock! Application to Today's Case: Today's patient developed ventricular septal rupture the evening after she was admitted to the hospital. Heart rate was in the 80s.

Cardiogenic Shock 109

Cardiogenic Shock Chest Pain Pericarditis Myocardial Infarction 109